Clinical trials recruiting in Tromsø, Norway

Phase breakdown

Conditions recruiting in Tromsø, Norway

Recruiting trials in Tromsø, Norway

• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
  NCT04844606 · Phase: Phase 3 · Ages: 2 Years to 19 Years · Sex: All (male and female)
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
  NCT07165028 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer
  NCT06944587 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
  NCT05923073 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female)
• A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
  NCT07577843 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
  NCT07577856 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
  NCT05509777 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female)
• A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
  NCT07753993 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study
  NCT07332260 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female)
• Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
  NCT06488482 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression
  NCT07312110 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female)
• DESTINY Breast Respond HER2-(Ultra)Low Europe
  NCT05945732 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)
  NCT06362707 · Phase: Phase 2 · Ages: 50 Years to 100 Years · Sex: All (male and female)
• Imaging Treat-to-target Strategy vs Conventional Treat-to-target Strategy in Psoriatic Arthritis
  NCT05291819 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
  NCT05448547 · Phase: Phase 3 · Ages: 75 Years and older · Sex: Male
• Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing
  NCT03889743 · Phase: Phase 4 · Ages: 3 Months to 23 Months · Sex: All (male and female)
• Ketamine for Combined Depression and Alcohol Use Disorder
  NCT06090422 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Management of Patients With Heart Failure at Home After Hospital Discharge
  NCT06576752 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer
  NCT05572801 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Norwegian Distal Ulna Resection - Replacement Study
  NCT04074863 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 75 Years · Sex: All (male and female)
• Partial Breast Versus no Irradiation for Women With Early Breast Cancer
  NCT03646955 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: Female
• Population-based Atrial Fibrillation Screening in Individuals With NT-proBNP Above Median in the Tromsø Study
  NCT07343895 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female)
• Pre- Vs Postoperative Thromboprophylaxis for Liver Resection
  NCT04731558 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)
• Prediction of Outcome by Echocardiography in Left Bundle Branch Block
  NCT04293471 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)
• ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
  NCT03903835 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)
  NCT06485336 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Prophylactic Treatment With Atorvastatin for Episodic Migraine.
  NCT06248671 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Prospective Natural History Study of POLG Disease
  NCT07775872 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• Speech-based Assessment of Relapse Risk in People With Psychosis
  NCT07397975 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
  NCT05679024 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
  NCT05855200 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer
  NCT02102477 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: Male
• The Cerebral and Cognitive Changes After Intermittent Theta Burst Stimulation (iTBS) Treatment for Depression
  NCT06534684 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 65 Years · Sex: All (male and female)
• The Covideo Study - a Trial of Cognitive Therapy for Social Anxiety Disorder in Youth, Comparing Screen to Office Delivery
  NCT06901128 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 18 Years · Sex: All (male and female)
• The Key to Integrated Trauma Treatment in Psychosis Trial
  NCT06608706 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years and older · Sex: All (male and female)
• The Norwegian Antirheumatic Drug Register
  NCT01581294 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.
  NCT05634889 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Thrombolysis in Factor Xa-inhibitors Trial
  NCT06878066 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Virtual Biopsy of Prostate Cancer Using PSMA PET and AI
  NCT07266129 · Phase: Not specified · Ages: No age limits stated · Sex: Male

Common questions

How many clinical trials are recruiting in Tromsø, Norway?

39 recruiting trials have at least one study site in Tromsø, Norway.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.